Search
Search Results
##search.searchResults.foundPlural##
-
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13011PDF: 1770HTML: 4369Cover letter: 270Figure 1: 284 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3467PDF: 1014HTML: 4643 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3625PDF: 2359HTML: 23625Untitled: 305Untitled: 287Untitled: 309 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2523PDF: 1169HTML: 2190Untitled: 219 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1351PDF: 578HTML: 23242 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4988PDF: 1943HTML: 2203 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1429PDF: 1123HTML: 454 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2667PDF: 1801HTML: 719 -
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY
1715PDF: 1003HTML: 271Figure 1: 215 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4731PDF: 3907HTML: 382 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2330PDF: 1680HTML: 714 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2551PDF: 1281HTML: 3912 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1108PDF: 1306HTML: 140 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1967PDF: 909HTML: 1669 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
254PDF: 238HTML: 109 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2443PDF: 2160HTML: 240 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2450PDF: 1905HTML: 1065 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1726HTML: 708PDF: 923 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1850PDF: 1395HTML: 668 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1272PDF: 819HTML: 1543Figure 1: 260Figure 2: 265 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7956PDF: 2525HTML: 2162Table 1.: 277Table 2.: 288Table 3.: 267Table 4.: 263 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1550PDF: 894HTML: 3147







